???global.info.a_carregar???
Identification

Personal identification

Full name
Vanessa Cardoso Pires Martins Correia

Citation names

  • Correia, Vanessa
  • Correia, V.

Author identifiers

Ciência ID
391A-1FCC-59C2
ORCID iD
0000-0002-1619-1900
Researcher Id
V-2507-2017
Scopus Author Id
54585076000

Email addresses

  • vanessa.correia@insa.min-saude.pt (Professional)
  • vanessacpmcorreia@hotmail.com (Personal)

Addresses

  • Instituto Nacional de Saúde Doutor Ricardo Jorge, Antiviral Resistance Lab, Research and Development Unit, Infectious Diseases Department, Avenida Padre Cruz, 1649-016, Lisbon, Lisbon, Portugal (Professional)

Knowledge fields

  • Medical and Health Sciences - Health Sciences - Infectious Diseases
  • Natural sciences - Biological Sciences - Virology

Languages

Language Speaking Reading Writing Listening Peer-review
English Advanced (C1) Proficiency (C2) Proficiency (C2) Proficiency (C2) Advanced (C1)
Spanish; Castilian Elementary (A2) Intermediate (B1) Elementary (A2) Intermediate (B1) Elementary (A2)
French Beginner (A1) Elementary (A2) Beginner (A1) Elementary (A2) Beginner (A1)
Education
Degree Classification
2009/10/01 - 2018/01/25
Concluded
 Health Science and Technologies (Doutoramento)
Major in Microbiology
Universidade de Lisboa Faculdade de Medicina, Portugal
"Influenza Virus Susceptibility to Antiviral Drugs – Drug Susceptibility Profiling, Whole-genome Mutational Landscape and Selective Pressure Footprints" (THESIS/DISSERTATION)
2001/09/01 - 2006/12/13
Concluded
 Biology (Licenciatura)
Universidade de Évora, Portugal
"Characterization and phylogeny of the neuraminidase gene of influenza viruses" (THESIS/DISSERTATION)
 17
Affiliation

Science

Category
Host institution 		Employer
2021/04/15 - Current Postdoc (Research) Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2020/01/01 - Current Researcher (Research) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2015/01/01 - 2017/12/31 Researcher (Research) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2012/01/01 - 2013/12/31 Researcher (Research) Universidade de Lisboa Faculdade de Farmácia, Portugal
2005/03/10 - 2006/10/06 Research Trainee (Research) Universidade de Évora, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Other Careers

Category
Host institution 		Employer
2021/04/15 - Current Técnico Superior (Técnico Superior) Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Others

Category
Host institution 		Employer
2016/12/15 - 2021/04/18 Research Service Provider in R&D Activities Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2013/02/02 - 2015/10/31 Research Grant Fellow Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2009/10/01 - 2013/09/30 PhD Research Student Fundação para a Ciência e a Tecnologia, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2007/01/15 - 2009/09/30 Research Grant Fellow Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Projects

Grant

Designation Funders
2023/02/01 - Current Delivering a Unified Research Alliance of Biomedical and public health Laboratories against Epidemics (DURABLE)
101102733
Researcher
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
 European Commission
Ongoing
2018/09/01 - 2022/08/31 Reverse Genetics Vaccine Seeds for Influenza: Mechanisms that drive the co-segregation of PB1 with antigenic proteins
PTDC/SAU-INF/30729/2017
Researcher
Universidade de Lisboa Faculdade de Farmácia, Portugal

Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2020/07/06 - 2021/07/05 Repurposed antimalarial and anti-Ebola drugs as Organic Salts and Ionic Liquids to prevent and fight COVID-19
Research 4 COVID-19 nº 582
Researcher
Associação para a Inovação e Desenvolvimento da FCT, Portugal

Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2009/08/18 - 2015/10/31 Evaluation and characterization of the emergence of resistance to influenza antiviral drugs in the context of acute respiratory infection
FCG SDH49
Integration into Research Grant Fellow
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
 Fundação Calouste Gulbenkian
Concluded
2012/01/02 - 2015/09/10 Functional compatibility of the replication complex as determinant of virulence in influenza viruses
PTDC/SAUMIC/122780/2010
Researcher
Universidade de Lisboa Faculdade de Farmácia, Portugal

Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2007/01/15 - 2009/10/30 Monitoring and surveillance of the susceptibility to influenza antiviral drugs
FCG 76676
Integration into Research Grant Fellow
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
 Fundação Calouste Gulbenkian
Concluded

Contract

Designation Funders
2020/01/01 - Current Research Institute for Medicines
UIDB/04138/2020
Researcher
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing

Other

Designation Funders
2013/02/02 - 2014/04/30 Influence of stress on the immune response to influenza vaccine in healthcare workers
ENSP 033Has
Integration into Research Grant Fellow
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
 Universidade Nova de Lisboa Escola Nacional de Saúde Pública
Concluded
2011/07/01 - 2013/03/29 Characterization and analysis of the mechanisms of molecular evolution associated with the development of influenza virus resistance to neuraminidase inhibitor antivirals
INSARJ ref 2012DDI749
Researcher
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
 Instituto Nacional de Saúde Doutor Ricardo Jorge
Concluded
Outputs

Publications

Conference paper
  1. Correia, Vanessa; Rebelo-de-Andrade, Helena. "Evolution of human influenza A virus neuraminidase gene and evaluation of susceptibility to antivirals". Paper presented in Options for the Control of Influenza VI, Toronto, 2007.
Conference poster
  1. Gonçalves, Paloma; Cheila Rocha; Correia, Vanessa; Luís A. Santos; Rebelo-de-Andrade, Helena; Bártolo, Inês; Nuno G. Alves; et al. Corresponding author: Nuno Eduardo Moura dos Santos da Costa Taveira. "Novel spiro-ß-lactams as promising broad-spectrum, host-directed drugs for the treatment of respiratory RNA virus infections". Paper presented in 14th iMed.ULisboa Meeting, 2023.
  2. Correia, Vanessa; Santos, Miguel; Santos, Luís A.; Faísca, Francisco; Branco, Luis; Rebelo-de-Andrade, Helena. "Novel formulations of Remdesivir as Organic Salts and Ionic Liquids (OSILs) show improved in vitro antiviral activity against SARS-CoV-2". Paper presented in 36th International Conference on Antiviral Research (ICAR), 2023.
  3. Bártolo, Inês; Moranguinho, Inês; Gonçalves, Paloma; Martin, Francisco; Borrego, Pedro; Alves, AJS; Alves, NG; et al. "Spiro-ß-lactam BSS-730A presents potent activity against RNA respiratory viruses and HIV". Paper presented in ASM Microbe, 2022.
  4. Faísca, Francisco; Correia, Vanessa; Branco, Luis; Rebelo-de-Andrade, Helena; Miguel M. Santos. Corresponding author: Miguel M. Santos. "Pharmaceutical Organic Salts and Ionic Liquids based on Hydroxychloroquine and Remdesivir as efficient drugs against SARS-CoV-2". Paper presented in 14th National Organic Chemistry Meeting & 7th National Medicinal Chemistry Meeting, 2022.
  5. Faísca, Francisco; Silva, Dário; Grilo, Inês R.; Correia, Vanessa; Alves, Celso; Silva, Joana; Susano, Patrícia; et al. Corresponding author: Branco, Luis. "TACKLING INFECTIOUS DISEASES USING PHARMACEUTICAL IONIC LIQUIDS". Paper presented in 7th Portuguese Young Chemists Meeting, 2021.
  6. Trigueiro-Louro, João; Figueiredo-Nunes, Inês; Santos, Luís A.; Almeida, Filipe; Correia, Vanessa; Guedes, Rita C.; Brito, Rui M.M.; Rebelo-de-Andrade, Helena. "Exploring influenza A and B therapeutics: NS1 as a potential universal antiviral target". Paper presented in The seventh ESWI Influenza Conference, Virtual Edition, 2020.
  7. Trigueiro-Louro, João; Santos, Luís A.; Almeida, Filipe; Correia, Vanessa; Brito, Rui M.M.; Rebelo-de-Andrade, Helena. "NS1 as a promising anti-influenza target: new putative druggable hot spots and their relevance on viral replication". Paper presented in The seventh ESWI Influenza Conference, Virtual Edition, 2020.
  8. Trigueiro-Louro, João; Correia, Vanessa; Figueiredo-Nunes, Inês; Gíria, Marta; Rebelo-de-Andrade, Helena. "Exploring coronavirus locks: Sequence-to-structure characterization of SARS-CoV-2, SARS-CoV and MERS-CoV proteins". Paper presented in The seventh ESWI Influenza Conference, Virtual Edition, 2020.
  9. Figueiredo-Nunes, Inês; Trigueiro-Louro, João; Correia, Vanessa; Gíria, Marta; Rebelo-de-Andrade, Helena. "Exploring antiviral strategies against a broad range of beta-CoVs: Spike and Polymerase proteins as promising anti-CoV targets". Paper presented in Special isirv-AVG Virtual Conference on “Therapeutics for COVID-19”, 2020.
  10. Correia, Vanessa; Santos, Luís A.; Trigueiro-Louro, João; Abecasis, Ana; Rebelo-de-Andrade, Helena. "Victoria and Yamagata: Exploiting lineage-specificity of influenza B virus neuraminidase inhibitor natural susceptibility and selective pressure strength at resistance-associated sites". Paper presented in OPTIONS X for the Control of Influenza, 2019.
  11. Trigueiro-Louro, João; Gíria, Marta; Santos, Luís A.; Correia, Vanessa; Rebelo-de-Andrade, Helena. "PB1-HA functional compatibility contributes to genome segregation patterns and to the overall viral fitness in A(H1N1)pdm09 vaccine seeds". Paper presented in OPTIONS X for the Control of Influenza, 2019.
  12. Trigueiro-Louro, João; Santos, Luís A.; Correia, Vanessa; Guedes, Rita; Rebelo-de-Andrade, Helena. "Unlocking the antiviral target potential of influenza A virus NS1 protein". Paper presented in OPTIONS X for the Control of Influenza, 2019.
  13. Trigueiro-Louro, João; Correia, Vanessa; Santos, Luís A.; Guedes, Rita; Rebelo-de-Andrade, Helena. "Na rota dos descobrimentos de novos alvos antivirais contra a gripe - Mapeamento computacional do domínio efetor da proteína NS1". Paper presented in V Congresso Nacional de Virologia, 2018.
  14. David, Susana; Correia, Vanessa; Antunes, Liliana; Faria, R.; Ferrão, José; Faustino, Paula; Nunes, Baltazar; et al. "Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity". Paper presented in 21a Reunião Anual da Sociedade Portuguesa de Genética Humana (SPGH), 2017.
  15. Trigueiro-Louro, João; Correia, Vanessa; Rebelo-de-Andrade, Helena. "A cost-efficient solution: reagent comparison guide for neuraminidase inhibition assay". Paper presented in 19th Annual Meeting of the European Society for Clinical Virology, 2016.
    10.5594/m001597
  16. Correia, Vanessa; Abecasis, Ana; Rebelo-de-Andrade, Helena. "Uncovering the role of positive selection in the evolutionary pathways to influenza virus resistance or reduced inhibition by neuraminidase inhibitors". Paper presented in Options IX for the Control of Influenza, 2016.
  17. Correia, Vanessa; Santos, Luís A.; Gíria, Marta; Rebelo-de-Andrade, Helena. "Evaluation and Characterization of Influenza Antiviral Drug Resistance in Portugal: Major Results and Achievements of a 5-Year Study". Paper presented in The second conference of the isirv-Antiviral Group (isirv-AVG) “Severe Influenza: Burden, Pathogenesis and Management”, 2012.
  18. Santos, Luís A.; Solá, Susana; Correia, Vanessa; Gíria, Marta; Rodrigues, Cecília MP; Rebelo-de-Andrade, Helena. "Different Mechanisms of Apoptosis by Influenza A and B Virus". Paper presented in The second conference of the isirv-Antiviral Group (isirv-AVG) “Severe Influenza: Burden, Pathogenesis and Management”, 2012.
  19. Correia, Vanessa; Santos, Luís A.; Gíria, Marta; Rebelo-de-Andrade, Helena. "Selective pressure acting on influenza virus neuraminidase protein and relation with development of resistance to antiviral drugs". Paper presented in 17th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology, 2012.
  20. Correia, Vanessa; Santos, Luís A.; Sousa Uva, Mafalda; Rebelo-de-Andrade, Helena. "Emergência de resistência aos antivirais específicos para a gripe: determinação do perfil antivírico de vírus influenza sazonais e da nova variante pandémica A(H1N1)v circulantes em Portugal". Paper presented in 7as Jornadas de Actualização em Doenças Infecciosas do Hospital de Curry Cabral, 2010.
  21. Correia, Vanessa; Rebelo-de-Andrade, Helena; Santos, Luís A.; Gíria, Marta. "Monitoring influenza antiviral susceptibility in Portugal from 2004/2005 to 2007/2008 winter seasons". Paper presented in The Third European Influenza Conference, 2008.
  22. Ruiz, Guillermo; Correia, Vanessa; Lackenby, Angie; Casas, I; Pozo, F; Rebelo-de-Andrade, Helena; Zambon, Maria; Perez-Brena, P. "Susceptibility to neuraminidase inhibitors of influenza viruses circulating in Spain". Paper presented in The Third European Influenza Conference, 2008.
  23. Correia, Vanessa; Rebelo-de-Andrade, Helena; Santos, Luís A.; Gíria, Marta. "Susceptibility to oseltamivir and amantadine of human influenza viruses circulating in Portugal". Paper presented in 13th International Congress on Infectious Diseases, 2008.
  24. Correia, Vanessa; Rebelo-de-Andrade, Helena. "Evolution of human influenza A virus neuraminidase gene and evaluation of susceptibility to antivirals". Paper presented in Options for the Control of Influenza VI, 2007.
Journal article
  1. Santos, Hugo M.; Carvalho, Luís B.; Lodeiro, Carlos; Martins, Gonçalo; Gomes, Inês L.; Antunes, Wilson D.T.; Correia, Vanessa; et al. "How to dissect viral infections and their interplay with the host-proteome by immunoaffinity and mass spectrometry: A tutorial". Microchemical Journal 186 (2023): 108323. http://dx.doi.org/10.1016/j.microc.2022.108323.
    10.1016/j.microc.2022.108323
  2. Faísca, Francisco; Correia, Vanessa; Petrovski, Željko; Branco, Luís C.; Rebelo-de-Andrade, Helena; Santos, Miguel M.. "Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2". Pharmaceutics 14 4 (2022): 877. http://dx.doi.org/10.3390/pharmaceutics14040877.
    10.3390/pharmaceutics14040877
  3. Trigueiro-Louro, João; Santos, Luís A.; Almeida, Filipe; Correia, Vanessa; Brito, Rui M.M.; Rebelo-de-Andrade, Helena. "NS1 protein as a novel anti-influenza target: Map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication". Virology 565 (2022): 106-116. http://dx.doi.org/10.1016/j.virol.2021.11.001.
    10.1016/j.virol.2021.11.001
  4. Trigueiro-Louro, João; Correia, Vanessa; Figueiredo-Nunes, Inês; Gíria, Marta; Rebelo-de-Andrade, Helena. "Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike". Computational and Structural Biotechnology Journal 18 (2020): 2117-2131. http://dx.doi.org/10.1016/j.csbj.2020.07.017.
    10.1016/j.csbj.2020.07.017
  5. Trigueiro-Louro, João M.; Correia, Vanessa; Santos, Luís A.; Guedes, Rita C.; Brito, Rui M.M.; Rebelo-de-Andrade, Helena. "To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential". Virology 535 (2019): 297-307. http://dx.doi.org/10.1016/j.virol.2019.04.009.
    10.1016/j.virol.2019.04.009
  6. Correia V; Abecasis AB; Rebelo-de-Andrade H. "Molecular footprints of selective pressure in the neuraminidase gene of currently circulating human influenza subtypes and lineages.". Virology (2018): http://europepmc.org/abstract/med/30029011.
    10.1016/j.virol.2018.07.002
  7. David, Susana; Correia, Vanessa; Antunes, Liliana; Faria, R.; Ferrão, José; Faustino, Paula; Nunes, Baltazar; et al. "Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.". Immunogenetics (2017): http://europepmc.org/abstract/med/28842783.
    10.1007/s00251-017-1026-2
  8. Louro, J.; Correia, V.; Rebelo-de-Andrade, H.. "A cost-efficient solution: Reagent comparison guide for neuraminidase inhibition assay". Journal of Clinical Virology 82 (2016): S119-S120. http://dx.doi.org/10.1016/j.jcv.2016.08.240.
    10.1016/j.jcv.2016.08.240
  9. Correia, Vanessa; Santos, Luís A.; Gíria, Marta; Santos, Madalena M.; Rebelo-de-Andrade, Helena. "Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.". Journal of Medical Virology (2015): http://europepmc.org/abstract/med/25042157.
    10.1002/jmv.23986
  10. Adam Meijer; Helena Rebelo-de-Andrade; Vanessa Correia; Terry Besselaar; Renu Drager-Dayal; Alicia Fry; Vicky Gregory; et al. "Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013". Antiviral Research 110 (2014): 31-41. https://doi.org/10.1016/j.antiviral.2014.07.001.
    10.1016/j.antiviral.2014.07.001
  11. Gíria, Marta; Rebelo-de-Andrade, Helena; Santos, Luís A.; Correia, Vanessa; Pedro, Sónia; Santos, Madalena M.. "Genomic signatures and antiviral drug susceptibility profile of A(H1N1)pdm09.". Journal of Clinical Virology (2012): http://europepmc.org/abstract/med/22177272.
    10.1016/j.jcv.2011.11.002
  12. Santos, Luís A.; Correia, Vanessa; Gíria, Marta; Pedro, Sónia; Santos, Madalena M.; Silvestre, Maria J.; Rebelo-de-Andrade, Helena. "Genetic and Antiviral Drug Susceptibility Profiles of Pandemic A(H1N1)v Influenza Virus Circulating in Portugal". Influenza and Other Respiratory Viruses 5 s1 (2011): 54-442. http://dx.doi.org/10.1111/j.1750-2659.2011.00209.x.
    10.1111/j.1750-2659.2011.00209.x
  13. Correia, Vanessa; Rebelo-de-Andrade, Helena; Santos, Luís A.; Lackenby, Angie; Zambon, Maria. "Antiviral drug profile of seasonal influenza viruses circulating in Portugal from 2004/2005 to 2008/2009 winter seasons.". Antiviral Research (2010): http://europepmc.org/abstract/med/20083142.
    10.1016/j.antiviral.2010.01.002
  14. Santos, Luís A.; Correia, Vanessa; Pedro, Sónia; Alverca, Elsa; Santos, Madalena M.; Silvestre, Maria J.; Rebelo-de-Andrade, Helena. "Caracterização genética da nova variante pandémica do vírus influenza A(H1N1) 2009 em circulação em Portugal: resultados preliminares". Revista Portuguesa de Doenças Infecciosas 6 1 (2010): 7-13.
  15. Correia, Vanessa; Santos, Luís A.; Rebelo-de-Andrade, Helena. "Emergência de resistência aos antivirais específicos para a gripe em Portugal". Revista Portuguesa de Doenças Infecciosas 5 1 (2009): 17-24.
Magazine article
  1. David, Susana; Correia, Vanessa; Antunes, Liliana; Faria, R; Ferrão, José; Faustino, Paula; Nunes, Baltazar; et al. "Variantes genéticas do gene IFITM3 revelam um potencial modificador da gravidade sintomática da gripe", Boletim epidemiológico Observações, Instituto Nacional de Saúde Doutor Ricardo Jorge, 2018, http://www.insa.min-saude.pt/category/informacao-e-cultura-cientifica/publicacoes/boletim-epidemiologico-observacoes-nume ro-23/.
  2. Correia, Vanessa; Santos, Luís A.; Rebelo-de-Andrade, Helena. "Perfil de suscetibilidade do vírus influenza aos antivirais específicos para a gripe de 2004 a 2011", Boletim epidemiológico Observações, Instituto Nacional de Saúde Doutor Ricardo Jorge, 2013, http://repositorio.insa.pt/bitstream/10400.18/1646/1/observações% 20Nº%20Especial%201%2020 13.pdf.
  3. Correia, Vanessa; Lourenço, Joana; Albuquerque, Sara. "Prevenção do cancro do colo do útero através da vacinação com virossomas – artigo de revisão", Mundo farmacêutico, 2005
Thesis / Dissertation
  1. Correia, Vanessa. "Influenza Virus Susceptibility to Antiviral Drugs – Drug Susceptibility Profiling, Whole-genome Mutational Landscape and Selective Pressure Footprints". PhD, Universidade de Lisboa Faculdade de Medicina, 2018. https://repositorio.ul.pt/handle/10451/32687.
  2. Correia, Vanessa. "Caracterização e filogenia do gene da neuraminidase dos vírus influenza". Degree, Universidade de Évora, 2006.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2024/04 Spiro-ß-lactams as broad-spectrum host-directed drugs for respiratory viruses (Abstract submitted) European Congress of Clinical Microbiology and Infectious Diseases 2024
(Barcelona, Spain)
2021/05/27 Enhanced formulations of Hydroxychloroquine as Organic Salts and Ionic Liquids to fight COVID-19 European Chemical Biology Symposium (ECBS)
Virtual Edition
2018/04/09 Influenza virus susceptibility to antiviral drugs (PhD summary presentation) Journal Club
Instituto Nacional de Saúde Dr. Ricardo Jorge, Departamento de Doenças Infecciosas (Lisbon, Portugal)
2014/11/03 Selective pressure acting on influenza neuraminidase gene: a complementary approach for studying the emergence and evolution of antiviral drug resistance and reduced susceptibility International Meeting on Emerging Diseases and Surveillance (IMED)
(Vienna, Austria)
2014/10/03 Large-scale differential selection analysis on influenza A and B neuraminidase gene: a new approach for studying antiviral drug resistance and reduced susceptibility III International Conference on Antimicrobial Research (ICAR)
(Madrid, Spain)
2012/11/30 Susceptibility of influenza viruses to antiviral drugs VI PhD Students Meeting IMM/CAML
Instituto de Medicina Molecular João Lobo Antunes (Lisbon, Portugal)
2011/11/26 Susceptibilidade dos vírus influenza aos antivirais específicos para a gripe Journal Club
Instituto Nacional de Saúde Dr. Ricardo Jorge, Departamento de Doenças Infecciosas (Lisbon, Portugal)
2011/07/07 Training Course to Testing: Portugal Perspective CNRL Influenza Antiviral Susceptibility Surveillance Training Course
Public Health England, Colindale (London, United Kingdom)
2011/04/06 Resistência aos Antivirais na Gripe Sazonal e Pandémica Comemorações do Dia Mundial da Saúde dedicado à Resistência aos Antimicrobianos
Instituto Nacional de Saúde Doutor Ricardo Jorge, INSA, IP (Lisbon, Portugal)
2010/09/06 Genetic and Antiviral Drug Susceptibility Profiles of Pandemic A(H1N1)v Influenza Virus Circulating in Portugal Options for the Control of Influenza VII
(Hong Kong SAR, China)
2010/06/21 Gripe sazonal e pandémica: emergência de resistências aos medicamentos antivirais
Universidade de Évora (Évora, Portugal)
2009/12/09 Emergência de resistência aos antivirais específicos para a gripe Workshop “Gripe”, VI Ciclo de Workshops AEFFUL-GIPES
Universidade de Lisboa, Faculdade de Farmácia (Lisbon, Portugal)
2009/11/13 A globalização e a emergência de novos vírus - Emergência de resistências aos antivirais específicos para a gripe III Jornadas Nacionais de Controlo da Infecção da Associação Nacional de Controlo de Infecção
Associação Nacional de Controlo de Infecção (Guimarães, Portugal)
2009/11/07 Gripe sazonal e pandémica: emergência de resistências III Congresso Nacional de Virologia/VII Encontro da Sociedade Portuguesa de Virologia
Sociedade Portuguesa de Virologia (Lisbon, Portugal)
2008/12/02 Gripe: aspectos de uma doença re(emergente) III Congresso Científico Anual do Núcleo de Estudantes de Farmácia da Associação Académica de Coimbra “Na Era do Terrorismo: Doenças Infecciosas”
Universidade de Coimbra, Faculdade de Farmácia (Coimbra, Portugal)
2007/11/09 Preliminary results on the evaluation of the susceptibility to antivirals of influenza viruses isolated in Portugal VIRGIL Influenza Antiviral Data Handling Workshop
Public Health England, Colindale (London, United Kingdom)
2007/09/22 Novos antivíricos no controlo da gripe II Congresso Nacional de Virologia/VI Encontro da Sociedade Portuguesa de Virologia
Sociedade Portuguesa de Virologia (Porto, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2023/09/01 - Current Exploring new antiviral targets for Dengue: mapping target regions in NS5
Co-supervisor of Inara dos Santos Ali
 Integrated Master in Pharmaceutical Sciences (Project I Discipline) (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2011/06/05 - 2011/06/08 CNRL Influenza Antiviral Susceptibility Surveillance Training Course | organized under the auspices of the Community Network of Reference Laboratories for Human Influenza in Europe (CNRL) and the European Centre for Disease Prevention and Control (ECDC). (2011/06/05 - 2011/06/08)
Workshop (Other)
 Public Health England Colindale, United Kingdom

National Institute for Medical Research, United Kingdom

Event participation

Activity description
Type of event 		Event name
Institution / Organization
2023/06/20 - 2023/06/20 The Present and Future of Treatment Oriented Surveillance | organized by the International Society for Influenza and other Respiratory Virus Diseases (ISIRV) in the context of the ISIRV Antiviral Group Webinar Series.
Seminar
 The Present and Future of Treatment Oriented Surveillance
International Society for Influenza and other Respiratory Virus Diseases (ISIRV), United Kingdom
2023/03/13 - 2023/03/13 International mpox outbreak: from laboratory diagnosis to molecular epidemiology and characterisation of transmission dynamics in Portugal | Seminar Ricardo Jorge
Seminar
 Surto internacional de mpox: do diagnóstico laboratorial à epidemiologia molecular e caracterização da dinâmica de transmissão em Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2023/01/24 - 2023/01/24 Updates on Diagnosis, Prevention, and Management of Respiratory Infections | organized by the International Society for Influenza and other Respiratory Virus Diseases (ISIRV) in the context of ISIRV Antiviral Group Webinar Series.
Seminar
 Updates on Diagnosis, Prevention, and Management of Respiratory Infections
International Society for Influenza and other Respiratory Virus Diseases, United Kingdom
2023/01/23 - 2023/01/23 Through networks and the arts: new ways of communicating between science and the community | Seminar Ricardo Jorge
Seminar
 Por redes e artes: novas vias de comunicação entre ciência e comunidade
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2022/11/22 - 2022/11/25 Ethics in scientific research | organized by the Ethics Committee of INSA, in collaboration with INSA's Scientific Council.
Workshop
 Ética na investigação científica
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2022/06/21 - 2022/06/21 Respiratory Virus Summit - Pandemic Preparedness: Where Science and Policy Meet | organized by the European Scientific Working Group on Influenza (ESWI)
Seminar
 Pandemic Preparedness: Where Science and Policy Meet
European Scientific Working Group on Influenza (ESWI), Belgium
2021/10/04 - 2021/10/04 COVID-19 treatment and medication | organized by the European Scientific Working group on Influenza (ESWI), in the context of the webinar series on Preparing for COVID-19, RSV Disease and Influenza concomitant outbreaks
Seminar
 COVID-19 treatment and medication
European Scientific Working Group on Influenza (ESWI), Belgium
2018/11/15 - 2018/11/16 Transport of Infectious Substances | organized by the Emergency Response and Bio-Preparedness Unit, Department of Infectious Diseases, INSA, IP, under the models and regulations of WHO (WHO certified)
Workshop
 Transporte de substâncias infeciosas (5ª ed)
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2018/11/12 - 2018/11/14 Biosafety level 2 and 3 laboratories | organized by the Emergency Response and Bio-Preparedness Unit, Department of Infectious Diseases, INSA, IP
Workshop
 Biossegurança em laboratórios de nível 2 e 3 (10ª ed)
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2018/10/22 - 2018/10/22 Emergency situations in containment areas - 4th NRBQ Seminar | organized by the Emergency Response and Bio-Preparedness Unit, Department of Infectious Diseases, INSA, IP
Seminar
 Situações de emergência em áreas de contenção
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2013/05/09 - 2013/05/09 Assessing the quality of DNA sequencing | organized by the Technology and Innovation Unit of the Human Genetics Department, INSA, IP,
Seminar
 Avaliação da qualidade da sequenciação de DNA
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2013/02/26 - 2013/03/22 Applied Biostatistics | Lisbon Academic Medical Centre (CAML) Doctoral Programme
Workshop
 Applied Biostatistics
Universidade de Lisboa Faculdade de Medicina, Portugal
2012/11/26 - 2012/11/26 Scientific Career Development | Lisbon Academic Medical Centre (CAML) Doctoral Programme
Workshop
 Scientific Career Development
Universidade de Lisboa Faculdade de Medicina, Portugal
2012/08/27 - 2012/08/31 17th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology - Evolutionary and Hypothesis Testing Advanced Module | held at Faculty of Medicine, University of Belgrade, Belgrade
Workshop
 17th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology
Katholieke Universiteit Leuven Rega Institute for Medical Research, Belgium

Medicinski fakultet Univerzitet u Beogradu, Serbia
2012/04/12 - 2012/04/13 Get the best from your sequences | Lisbon Academic Medical Centre (CAML) Doctoral Programme
Workshop
 Get the best from your sequences
Universidade de Lisboa Faculdade de Medicina, Portugal
2011/11/25 - 2011/11/25 Biosafety: Portugal Situation | organized by the Emergency Response and Bio-Preparedness Unit, Department of Infectious Diseases, INSA, IP
Workshop
 Biossegurança: Situação em Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2011/07/11 - 2011/07/15 Training at the Respiratory Virus Unit, Virus Reference Department, Health Protection Agency (HPA), Colindale (London, UK) | training in a new plaque reduction assay protocol for virus titration (pfu/ml)
Other
Public Health England Colindale, United Kingdom
2011/07/14 - 2011/07/14 Training at the WHO Collaborating Center for Reference and Research on Influenza, NIMR, The Ridgeway, Mill Hill (London, UK) | training in new reference protocols of hemagglutination assay and hemagglutination inhibition assay with oseltamivir
Other
National Institute for Medical Research, United Kingdom
2009/04/20 - 2009/04/21 Molecular Detection of Pathogens | Speaker: Doctor Andreas Nitsche, Robert Koch Institute (Berlin, Germany)
Seminar
 Molecular Detection of Pathogens
Instituto Politécnico de Setúbal, Portugal
2007/11/09 - 2007/11/09 VIRGIL Influenza Antiviral Data Handling Workshop | organized under the umbrella of the European Surveillance Network for Vigilance against Viral Resistance (VIRGIL)
Workshop
 VIRGIL Influenza Antiviral Data Handling
Public Health England Colindale, United Kingdom
2007/08/27 - 2007/09/14 Training at the Respiratory Virus Unit, Virus Reference Department, Health Protection Agency (HPA), Colindale (London, UK) | training in genotypic evaluation of influenza virus susceptibility to M2 protein inhibitors by pyrosequencing and statistical analysis of phenotypic neuraminidase inhibitor susceptibility data
Other
Public Health England Colindale, United Kingdom
2006/10/03 - 2006/10/06 VIRGIL Training Course on Laboratory Methods for Antiviral Susceptibility | organized by the European Surveillance Network for Vigilance against Viral Resistance (VIRGIL)
Workshop
 VIRGIL Training Course on Laboratory Methods for Antiviral Susceptibility
Public Health England Colindale, United Kingdom

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2011 - 2012 Virology | Assistant of Prof. Helena Rebelo de Andrade in the practical sessions Integrated Master in Pharmaceutical Sciences (Mestrado integrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2011/06/05 - 2011/06/08 CNRL Influenza Antiviral Susceptibility Surveillance Training Course | Instructor Public Health England Colindale, United Kingdom

The Francis Crick Institute, United Kingdom
2010 - 2011 Virology | Assistant of Prof. Helena Rebelo de Andrade in the practical sessions Integrated Master in Pharmaceutical Sciences (Mestrado integrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2004 - 2005 Biotechnology | Assistant of Prof. Carlos Sinogas in the practical sessions BSc (Hons) in Biology (Licenciatura) Universidade de Évora, Portugal

Mentoring / Tutoring

Topic Student name
2023/04/05 - 2023/06/05 Phd Student | Mentoring for in vitro evaluation of cytotoxicity and anti-influenza virus activity of compounds in the work "Spiro-ß-lactams as broad-spectrum host-directed drugs for RNA respiratory viruses". Supervisor: Prof. Dr. Nuno Taveira Paloma Catarina Barradas Gonçalves (2022.14515.BD, Nova School of Science and Tecnology)
2017/01/01 - 2021/02/28 Phd student | Tutoring and assistance in supervision of the work on "The influenza virus NS1 protein as an emerging therapeutic target". Supervisor: Prof. Dr. Helena Rebelo de Andrade João Manuel Trigueiro Louro (FCT PD/BD/128402/2017, PhD Programme i3DU, FFUL)
2017/03/05 - 2017/03/20 Master student | Mentoring in biosafety management and procedures in a Biosafety level 2 laboratory Gabriela Simões (Faculty of Science, Universidade de Lisboa)
2013/11/12 - 2013/11/16 Health professionals | Mentoring and coaching for the establishment of influenza antiviral resistance testing capacity in Turkey Members of the National Influenza Center, Public Health Institutions of Turkey (Ankara, Turkey)
2013/09/24 - 2013/09/30 Master student | Mentoring in working in a Biosafety level 2 laboratory, multiple sequence alignment and phylogenetic methods and procedures, and genotypic evaluation of influenza antiviral resistance. Supervisor: Prof. Dr. Helena Rebelo de Andrade João Manuel Trigueiro Louro (Integrated Master in Pharmaceutical Sciences, FFUL)
2013/09/01 - 2013/09/30 Master student | Mentoring and coaching in biosafety management and procedures in a Biosafety level 2 laboratory and in influenza virus isolation and propagation in cell culture. Supervisor: Prof. Dr. Helena Rebelo de Andrade Vanessa Sofia Antunes Farias (Master in Microbiology, Universidade de Aveiro)
2009/10/22 - 2009/10/22 Health professionals | Mentoring for phenotypic influenza antiviral susceptibility testing by in-house MUNANA-based assay Patrícia Conde; Raquel Guiomar (National Influenza Reference Laboratory, Portugal, INSA, IP)
2008/09/22 - 2009/10/02 Master student | Tutoring and assistance in supervision on the work on "Susceptibility of influenza viruses circulating in Portugal to zanamivir". Supervisor: Prof. Dr. Helena Rebelo de Andrade Mafalda Bernes de Sousa Uva (Master in Applied Microbiology, Faculty of Science,Universidade Lisboa)
2007/11/26 - 2007/11/29 Health professional | Mentoring and coaching for phenotypic influenza antiviral susceptibility testing in Spain Guillermo Ruiz, National Center for Microbiology, Instituto de Salud Carlos III

Other jury / evaluation

Activity description Institution / Organization
2024/02 - 2024/02 Jury in the competition for the award of a Post-Doctoral Fellowship under the DURABLE Project - Delivering a Unified Research Alliance of Biomedical and public health Laboratories against Epidemics (Reference 101102733), promoted by the EU4Health Programme (EU4H), funded by the European Commission (Ref. 2024.DDI.DURABLE_01) Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Distinctions

Other distinction

2009 PhD Research Studentship - FCT SFRH/BD/48532/2008
Fundação para a Ciência e a Tecnologia, Portugal
2008 Award Student of the Year - Universidade de Évora
Universidade de Évora, Portugal
2005 Award of Merit | 2004/2005
Universidade de Évora, Portugal
2004 Award of Merit | 2003/2004
Universidade de Évora, Portugal
2002 Award of Merit | 2001/2002
Universidade de Évora, Portugal